Jiang et al. [21] observed that ovarian cancer cells with iASPP overexpression conferred resistance to paclitaxel by reducing mitotic catastrophe via activation of separase, whereas knockdown of iASPP enhanced paclitaxel-mediated mitotic catastrophe through inactivating separase. The gene discussed is ESPL1; the disease is ovarian carcinoma.